News and Announcements

GSK Q2 revenues grow, expects FY performance to be top end of guidance

By Iain Gilbert

Date: Wednesday 30 Jul 2025

(Sharecast News) - Drugmaker GSK said on Wednesday that Q2 revenues had grown as a strong specialty medicines performance drove sales and core operating profit growth.
GSK said Q2 revenues were 5% at £8.1bn, buoyed by its vaccines and specialty medicines divisions, while operating profits climbed 12% to £2.1bn, and adjusted...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page